ERBB2 and invasive breast carcinoma: The treatment strategy should be determined taking into consideration the prognostic or predictive factors, including the TNM stage, estrogen receptor (ER), progesterone receptor (PgR), HER2 status, histological grade, nuclear grade, Ki67-index, age, menopausal status, and general condition, as for other invasive breast cancers.